- 16 min ago The Viral Video Of Men Dressed As Women Hints At Growing Popularity Of Androgynous Fashion
- 2 hrs ago Priyanka Chopra Jonas Proves How Confidence Can Help You Rock Any Given Bold Attire
- 2 hrs ago Bella Hadid Makes A Bold Statement At Max Mara’s Show; Here’s How To Get This Look
- 2 hrs ago Mouni Roy Is A Picture Of Elegance In This White Belted Sari
- News Diplomatic win: How India ensured that Pakistan failed to move Kashmir resolution at UNHRC
- Movies Kaappaan Full Movie Leaked Online By Tamilrockers On Day 1!
- Sports England Central Contract: Jofra Archer handed Test, limited over deal for the first time
- Automobiles Benelli Leoncino 250 India Launch Expected Soon: Specs, Details & Price
- Finance Airbnb Plans To Go Public In 2020
- Technology Google To Soon Launch Feature Phone With Assistant Support
- Education Top 10 Indian Universities In QS Graduate Employability Rankings 2020
- Travel How To Spend 3 Days In Goa: A Complete Travel Guide
Using hormone replacement therapy drugs are likely to increase the risk of older women becoming deaf, warns a study.
Hormone replacement therapy is treatment with oestrogens, the female sex hormone, with the aim of alleviating menopausal symptoms such as hot flashes and vaginal dryness, and sometimes conditions like osteoporosis -- a condition in which bones become weak and brittle.
Previous studies had suggested that menopause may increase the risk for hearing loss, due to a reduction in oestrogen levels.
"Many factors contribute to acquired hearing loss, including age, genetics, noise, medical conditions, diet and lifestyle factors. Our research focuses on identifying preventable contributors to hearing loss," lead author Sharon Curhan at Brigham and Women's Hospital in Massachusetts, was quoted as saying by express.co.uk.
"Although the role of sex hormones in hearing is complex and not completely understood, these findings suggest that women who undergo natural menopause at an older age may have a higher risk," she added.
For the study, detailed in the journal Menopause, the team examined independent links between menopausal status, oral hormone therapy, and risk of self-reported hearing loss in 80,972 women.
The results showed that 23 per cent of the participants suffered hearing loss.
No significant overall association between menopausal status and risk of hearing loss was found, although higher risk was associated with older age at natural menopause.
In addition, the risk was found to increase the longer women took the drugs.
These findings suggest that hearing health may be a consideration for women when evaluating the risks and benefits of hormone therapy, the researchers suggested.
With Inputs From IANS